Skip to Main Content

Author Details

Guo Chen
China Pharmaceutical University
2009
62
30
PMIDPaper TitleJournal TitlePublished Year
36768413Myelin Basic Protein Fragmentation by Engineered Human Proteasomes with Different Catalytic Phenotypes Revealed Direct Peptide Ligands of MS-Associated and Protective HLA Class I Molecules.Int J Mol Sci2023
37409632NRF1-mediated mitochondrial biogenesis antagonizes innate antiviral immunity.EMBO J2023
36768413Myelin Basic Protein Fragmentation by Engineered Human Proteasomes with Different Catalytic Phenotypes Revealed Direct Peptide Ligands of MS-Associated and Protective HLA Class I Molecules.Int J Mol Sci2023
36847607Saturated fatty acids increase LPI to reduce FUNDC1 dimerization and stability and mitochondrial function.EMBO Rep2023
37409632NRF1-mediated mitochondrial biogenesis antagonizes innate antiviral immunity.EMBO J2023
36847607Saturated fatty acids increase LPI to reduce FUNDC1 dimerization and stability and mitochondrial function.EMBO Rep2023
35913115Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.Elife2022
35913115Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.Elife2022
35504898Dynamic O-GlcNAcylation coordinates ferritinophagy and mitophagy to activate ferroptosis.Cell Discov2022
35977480Nondegradable ubiquitinated ATG9A organizes Golgi integrity and dynamics upon stresses.Cell Rep2022
36480470β-Elemene regulates epithelial-mesenchymal transformation and inhibits invasion and metastasis of colorectal cancer cells.J Complement Integr Med2022
35504898Dynamic O-GlcNAcylation coordinates ferritinophagy and mitophagy to activate ferroptosis.Cell Discov2022
36480470β-Elemene regulates epithelial-mesenchymal transformation and inhibits invasion and metastasis of colorectal cancer cells.J Complement Integr Med2022
35977480Nondegradable ubiquitinated ATG9A organizes Golgi integrity and dynamics upon stresses.Cell Rep2022
33336620Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy.Cancer Biol Ther2021
33909912Inhibition of Syk promotes chemical reprogramming of fibroblasts via metabolic rewiring and H<sub>2</sub> S production.EMBO J2021
34225908Monitoring TFEB translocation.Methods Cell Biol2021
33658396Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.Aging (Albany NY)2021
33336620Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy.Cancer Biol Ther2021
34741014USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1.Cell Death Dis2021
34729307<i>Salmonella</i> flagella confer anti-tumor immunological effect <i>via</i> activating Flagellin/TLR5 signalling within tumor microenvironment.Acta Pharm Sin B2021
34373755Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.Theranostics2021
33909912Inhibition of Syk promotes chemical reprogramming of fibroblasts via metabolic rewiring and H<sub>2</sub> S production.EMBO J2021
33658396Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.Aging (Albany NY)2021
34729307<i>Salmonella</i> flagella confer anti-tumor immunological effect <i>via</i> activating Flagellin/TLR5 signalling within tumor microenvironment.Acta Pharm Sin B2021
34741014USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1.Cell Death Dis2021
34373755Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.Theranostics2021
34225908Monitoring TFEB translocation.Methods Cell Biol2021
32671064Mitophagy, Mitochondrial Homeostasis, and Cell Fate.Front Cell Dev Biol2020
32671064Mitophagy, Mitochondrial Homeostasis, and Cell Fate.Front Cell Dev Biol2020
31324785Acetylation regulates ribonucleotide reductase activity and cancer cell growth.Nat Commun2019
31662324Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.Cancer Res2019
31324785Acetylation regulates ribonucleotide reductase activity and cancer cell growth.Nat Commun2019
31662324Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.Cancer Res2019
29244158ZNF830 mediates cancer chemoresistance through promoting homologous-recombination repair.Nucleic Acids Res2018
30263905Cell Synchronization by Double Thymidine Block.Bio Protoc2018
30389289Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity.Bioorg Med Chem Lett2018
29227281Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.J Clin Invest2018
29180609Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.Clin Cancer Res2018
29244158ZNF830 mediates cancer chemoresistance through promoting homologous-recombination repair.Nucleic Acids Res2018
30263905Cell Synchronization by Double Thymidine Block.Bio Protoc2018
30389289Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity.Bioorg Med Chem Lett2018
29180609Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.Clin Cancer Res2018
29227281Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.J Clin Invest2018
28928360Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.Nat Commun2017
28423513miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.Oncotarget2017
28381544Modulation of Bax and mTOR for Cancer Therapeutics.Cancer Res2017
28928360Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.Nat Commun2017
28571917Targeting miR-21 with Sophocarpine Inhibits Tumor Progression and Reverses Epithelial-Mesenchymal Transition in Head and Neck Cancer.Mol Ther2017
28740548Modulation of <i>Salmonella</i> Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism.Theranostics2017
  • 1 - 50 of 124

Recommended Authors

Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Shruthy Suresh
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 1
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Jin-Ku Lee
Seoul National University, College of Medicine
Career Start Year 2010
Number of shared co-authors 0
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 9
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 6
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Career Start Year 2008
Number of shared co-authors 3
Xi Liu
College of Biology and Food, Shangqiu Normal University
Career Start Year 2007
Number of shared co-authors 10
Shweta Joshi
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 5
Guan Wang
Jilin University
Career Start Year 2005
Number of shared co-authors 0
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 1
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 3
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 12
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 0
Yongmei Feng
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2002
Number of shared co-authors 9
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 1
Vivek Shukla
Chalmers University of Technology
Career Start Year 2000
Number of shared co-authors 2
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 1
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 1
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 5
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 1
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 11
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 2
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 6

Collaborators

Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 16
Jennifer A Wargo
Co-authored papers 5
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Andrew T Magis
Institute for Systems Biology
Co-authored papers 4
Pan Du
Co-authored papers 3
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 2
Ian R Watson
Co-authored papers 2
Nicholas K Hayward
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Jimmy C Lin
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 2
Ken Dutton-Regester
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Georgina V Long
Co-authored papers 2
Todd D Prickett
National Cancer Institute
Co-authored papers 2
Elliott H Margulies
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 2
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 2
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Steven E Robinson
University of Colorado Anschutz Medical Campus
Co-authored papers 2
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 2
Stephan N Wagner
Co-authored papers 2
Stephen C J Parker
University of Michigan ann arbor
Co-authored papers 2
Richard A Scolyer
Co-authored papers 2
Xiaomu Wei
Cornell University
Co-authored papers 2
Hannah Carter
University of California San Diego
Co-authored papers 1
Nobuko Hamasaki-Katagiri
Center for Biologics Evaluation & Research
Co-authored papers 1
Alex H Ramos
Co-authored papers 1
Michael Noble
Co-authored papers 1
Timothy P Heffernan
Co-authored papers 1
Release 1.2